C12Y 304/23015
Renin
Official title: Renin (3.4.23.15)
C12Y304/23015 (Renin) appears on 18 US grants and 14 published applications in this corpus.
Search patents in C12Y- Granted patents
- 18
- Published applications
- 14
- Assignees
- 13
- Inventors
- 29
- Latest grant
- 8 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 3 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 2 | 2 |
| 2018 | 3 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Mirac proteins8 Aug 2023US 11,718,844 B2BioAtla, Inc.
- Mirac proteins12 Jun 2018US 9,994,841 B2BioAtla, Inc.
- Mirac proteins29 May 2018US 9,982,252 B2BioAtla, Inc.
- Use of angiotensin II (AII) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps20 Mar 2018US 9,919,022 B2
- Mirac proteins2 May 2017US 9,637,734 B2BioAtla, Inc.
- Mirac proteins19 Oct 2023US 2023/0332135 A1BioAtla, Inc.
- Compositions acting as pro(renin) receptor antagonists for the treatment of non-alcoholic fatty liver disease14 Oct 2021US 2021/0315971 A1Board of Regents of the Nevada System of Higher Education, on behalf of the University of Nevada, Reno
- Mirac proteins28 Dec 2017US 2017/0369867 A1BioAtla, Inc.
- Mirac proteins16 Feb 2017US 2017/0044522 A1BioAtla, Inc.
- Use of angiotensin ii (aii) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps22 Sep 2016US 2016/0271205 A1ATKINSON, Arthur J.
Most cited
By later US patents
- Plant potyvirus expression vector with a gene for protease94US 5,162,601 AThe Upjohn Company · 1992
- Superior mammalian expression system43US 5,089,397 ACalifornia Biotechnology Inc. · 1992
- Mirac proteins26US 8,709,755 B2BioAtla, Inc. · 2014
- Genetically engineered bacteria to identify and produce medically important agents4US 5,532,124 AThomas Jefferson University · 1996
- Prorenin antibody and renin-active substance containing the same4US 5,945,512 ATokiwa Chemical Industries Co., Ltd. · 1999